Stock screenerAll disclosures →
EDGAR →
FATE
Conviction 82HealthcareScan · Thu, Jun 25, 2026FATE$1.85-10.19%
ResistanceSupportVol 14Insider sell2
Vol MA14 3.9M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.85
Change-10.19%
Gap+0.97%
Rel volume2.64×
Avg volume4.39M
Avg $ vol9.71M
SMA 202.15
SMA 501.93
SMA 2001.37
Price vs 50-3.99%
Price vs 200+34.75%
MA stackmixed
50/200 cross—
Supertrenddown · 2.59
RSI (14)44
MACD hist-0.03
MACD cross—
Stoch %K / %D7 / 33
ADX (14)13
+DI / −DI22 / 22
RSI divergence—
MACD divergence—
ATR %+12.49%
ADR %10.78%
52w high2.84
52w low0.9214
From 52w high-34.86%
Above 52w low+100.78%
New 52w highNo
SqueezeOff
Bollinger width54.57%
%B0.24
Donchian pos3.29%
Donchian high2.88
Donchian low1.82
AVWAP (52w high)2.20
vs AVWAP high-15.92%
AVWAP (52w low)1.55
vs AVWAP low+19.31%
OBV trendFlat
Chaikin MF (20)-0.14
Today vs 20d2.64×
Avg vol (14d)3.9M
Avg vol (20d)4.39M
Avg $ vol (20d)9.71M
Market cap215.63M
RS 3m (vs SPY)+70.04%
RS 6m (vs SPY)+88.45%
RS line new highNo
Trend template6/8
Technical rank62.9
1 week-5.61%
1 month-13.95%
3 months+51.64%
6 months+76.19%
1 year+58.12%
YTD+87.55%
P/E-1.58
P/B1.20
P/S32.45
P/FCF-1.92
EPS-1.15
Div yield—
ROE-75.85%
ROA-47.84%
Debt/Eq0.13
Current5.85
EV/EBITDA-1.48
Gross margin—
Net margin—
Rev growth-51.24%
EPS growth26.82%
Price target5.24
Target upside183.24%
Analyst ratingBuy
Institutional72.70%
Ent. value199.47M
Revenue1.3M
Net income-31.21M
Gross profit—
Free cash flow-112.04M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out—
Employees161
ListedTue, Oct 1, 2013
Free float98.83M
Float %85.0%
Short interest10.7M
Days to cover2.1d
Short volume40.7%
Squeeze score47 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.26 vs −$0.29
Last surprise+10.3% beat
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank62.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.67
Support1.71
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in FATE
No recent disclosed trades by Congress in FATE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in FATE · 5 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Valamehr Bahram President and CEO · Common Stock · 2026-05-20 | Sell | 28.95K | $54K | 2026-05-20 | 2026-05-21 |
TAHL CINDY See Remarks · Common Stock · 2026-05-20 | Sell | 25.59K | $48K | 2026-05-20 | 2026-05-21 |
TAHL CINDY See Remarks · Common Stock · 2026-05-06 | Exercise | 122.22K | $161K | 2026-05-06 | 2026-05-07 |
TAHL CINDY See Remarks · Stock Option (Right to Buy) · 2026-05-06 | Exercise | 44.44K | $0 | 2026-05-06 | 2026-05-07 |
TAHL CINDY See Remarks · Stock Option (Right to Buy) · 2026-05-06 | Exercise | 122.22K | $0 | 2026-05-06 | 2026-05-07 |
TAHL CINDY See Remarks · Common Stock · 2026-05-06 | Exercise | 44.44K | $47K | 2026-05-06 | 2026-05-07 |
EPSTEIN ROBERT S Director · Stock Option (Right to Buy) · 2026-05-05 | Exercise | 25K | $0 | 2026-05-05 | 2026-05-06 |
RASTETTER WILLIAM H Director · Common Stock · 2026-05-05 | Other | — | — | 2026-05-05 | 2026-05-06 |
RASTETTER WILLIAM H Director · Common Stock · 2026-05-05 | Exercise | 25K | $42K | 2026-05-05 | 2026-05-06 |
RASTETTER WILLIAM H Director · Stock Option (Right to Buy) · 2026-05-05 | Exercise | 25K | $0 | 2026-05-05 | 2026-05-06 |
SEC filings
EDGAR filings in FATE · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.